Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
NCT01401517
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Arterial Disease
Interventions
DRUG:
sodium nitrite
Sponsor
TheraVasc Inc.